Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
3-Cyanoaryl-1H-pyrrolo[2,3-B] pyridine derivatives
US9102675B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9102675-B2 |
| Application number | US-201214359705-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 30, 2012 |
| Priority date | Nov 22, 2011 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of the formula (I) in which R 1 , R 2 , X and Y have the meanings indicated in claim 1 , are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of formula I in which X denotes CH or N, R 1 denotes H, A or Cyc, R 2 denotes O[C(R 6 ) 2 ] n Het 1 or O[C(R 6 ) 2 ] n Cyc, R 3 denotes O[C(R 6 ) 2 ] n Het 2 , Ar or Het 2 , R 4 denotes H or OR 6 , R 5 denotes H or OR 6 , R 6 denotes H or methyl, Het 1 denotes dihydropyrrolyl, pyrrolidinyl, azetidinyl, oxetany…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9102675B2 cover?
- Compounds of the formula (I) in which R 1 , R 2 , X and Y have the meanings indicated in claim 1 , are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
- Who is the assignee on this patent?
- Merck Patent Gmbh
- What technology area does this patent fall under?
- Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).